HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of intra-arterial norcantharidin in suppressing tumour 14C-labelled glucose oxidative metabolism in rat Morris hepatoma.

Abstract
Norcantharidin is the demethylated form of Cantharidin, which is the active ingredient of the blister beetle, Mylabris, a long used Chinese traditional medicine. Though not well publicized outside China, Norcantharidin is known to possess significant anti-hepatoma activity, and is relatively free from side effects. In the present study, glucose oxidation in tumour and liver tissue slices harvested from hepatoma-bearing animals was quantified by measuring the radioactivity of 14C-labelled CO2 released from 14C-glucose in oxygen-enriched incubation medium. Results were expressed as a tumour/liver ratio. For comparison, treatments with Norcantharidin, Adriamycin and with hepatic artery ligation were studied. The mean tumour/liver ratio was 4.2 +/- 2.2 in untreated controls, but dropped significantly to 2.3 +/- 0.5 (p < 0.05) with intra-arterial Norcantharidin (0.5 mg/kg) and to 2.3 +/- 0.7 (p < 0.05) with intra-arterial Adriamycin (2.4 mg/kg), and to 2.2 +/- 0.7 (p < 0.05) with hepatic artery ligation. However, with intravenous Adriamycin at 2.4 mg/kg, the mean tumour/liver ratio was reduced to only 3.5 +/- 2.0 and was not significantly different from untreated controls. It is concluded that intra-arterial Norcantharidin is as effective as intraarterial Adriamycin and hepatic artery ligation in suppressing tumour glucose oxidative metabolism. These result simply that Norcantharidin may have a role to play in the chemotherapy of primary liver cancer.
AuthorsP Mack, X F Ha, L Y Cheng
JournalHPB surgery : a world journal of hepatic, pancreatic and biliary surgery (HPB Surg) Vol. 10 Issue 2 Pg. 65-72 ( 1996) ISSN: 0894-8569 [Print] United States
PMID9184858 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Bridged Bicyclo Compounds, Heterocyclic
  • Carbon Radioisotopes
  • Doxorubicin
  • norcantharidin
  • Glucose
Topics
  • Animals
  • Antibiotics, Antineoplastic (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Bridged Bicyclo Compounds, Heterocyclic (therapeutic use)
  • Carbon Radioisotopes (metabolism)
  • Carcinoma, Hepatocellular (drug therapy, metabolism)
  • Doxorubicin (therapeutic use)
  • Drug Evaluation, Preclinical
  • Glucose (metabolism)
  • Hepatic Artery (surgery)
  • Infusions, Intra-Arterial
  • Ligation
  • Liver Neoplasms, Experimental (drug therapy, metabolism)
  • Male
  • Oxidation-Reduction
  • Rats
  • Rats, Inbred BUF

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: